Tobacco smoke and risk of bacterial infection;Exposition à la fumée du tabac et risque infectieux bactérien

Revue des Maladies Respiratoires

Volumn 21, Issue 3 I, 2004, Pages 539-547

  Trosini Desert, V ^a   Germaud, P ^b   Dautzenberg, B ^a,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Bacterial Infection; Pneumonia; Risk Factors; Smoking; Tuberculosis

Indexed keywords

TOBACCO SMOKE;

BACTERIAL INFECTION; BACTERIUM ADHERENCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; HEALTH CARE COST; HUMAN; IMMUNE RESPONSE; INFECTION RISK; LUNG TUBERCULOSIS; OTITIS MEDIA; PASSIVE SMOKING; PNEUMONIA; POSTOPERATIVE INFECTION; REVIEW; SMOKING CESSATION; STREPTOCOCCUS PNEUMONIA;

EID: 3242795750     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(04)71358-3     Document Type: Review

References (35)

1. Goetgheebeur D, Leroyer C: Prévention des infections respiratoires basses. Prise en charge des infections respiratoires: facteurs du succès, analyse de l'échec. P Géhanno, P Léophonte, Y Mouton. EDK, Paris 2003, pp 113-8.
2. Almirall J, Bolibar I, Balanzo X, Gonzales CA: Risk factors for community-acquired pneumoniae in adults: a population-based case control study. Eur Respir J 1999; 13: 349-55.
3. Nuorti JP, Butler JC, Farley MM, Harrison LH, Mc Geer A, Kolczak MS: Cigarette smoking and invasive pneumococcal disease. N Engl J Med 2000; 34: 681-9.
4. Strauss WL, Plouffe JF File TM, Lipman HB, Hackman BH, Salstrom SJ: Risk factors for domestic acquisition of legionnaires disease. Ohio legionnaires Disease Group. Arch Intern Med 1996; 156: 1685-92.
5. Mizooka M, Ishikawa S: JMS Prevalence of Chlamydia pneumoniae in Japanese rural districts; association of smoking and physical activity with Chlamydia pneumoniae seropositivity. Cohort Study Group. Infection à Chlamydia. Intern Med 2003; 42: 960-6.
6. von Hertzen L, Kaprio J, Koskenvuo M, Isoaho R, Saikku P: Humoral immune response to Chlamydia pneumoniae in twin discordant for smoking. J Intern Med 1998; 244: 227-34.
7. Zalacain R, Sobradillo V, Amilibia J, Barron J, Achotegui V, Pijoan JI, Llorente JL: Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 343-8.
8. Monsó E, Rosell A, Bonet G, Manterola J, Cardona PJ, Ruiz J, Morera J: Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J 1999; 13: 338-42.
9. Dautzenberg B: Le tabagisme passif. Documentation Française Paris, 2001, 200 pages.
10. Strachan DP, Cook DG: Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood Thorax 1997; 52: 905-14.
11. Strachan DP, Cook DG: Health effects of passive smoking. 4. Parental smoking, middle ear disease and adenotonsillectomy in children. Thorax 1998; 53: 50-6.
12. Bredfeldt RC, Cain SR, Schutze GE, Holmes TM, McGhee LA: Relation between passive tobacco smoke exposure and the development of bacterial meningitis in children. J Am Board Fam Pract 1995; 8: 95-8.
13. Iles K, Poplawski NK, Couper RT: Passive exposure to tobacco smoke and bacterial meningitis in children. J Paediatr Child Health 2001; 37: 388-91.
14. Stanwell-Smith RE, Stuart JM, Hughes AO, Robinson P, Griffin MB, Cartwright K: Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect 1994; 112: 315-28.
15. Gajaalakshmi I V, Peto R, Kanaka S, Jha P: Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43,000 adult male deaths and 35,000 controls. Lancet 2003; 362: 507-15.
16. Caiaffa WT, Vlahov D, Graham NM, Astemborski J, Solomon L, Nelson KE, Munoz A: Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med 1994; 150: 1493-8.
17. Miguez-Burbano MJ, Burbano X, Ashkin D, Pitchenik A, Allan R, Pineda L, Rodriguez N, Shor-Posner G: Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict Biol 2003; 8: 39-43.
18. Moller AM, Villebro N, Pedersen T, Tonnesen H: Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002; 359: 114-7.
19. Wanner A, Salathe M, O'Riodan TG: Mucociliary clearance in the airways. Am J Respir Crit Care Med 1996; 154: 1868-902.
20. Hirabayashi H, Koshiil K, Uno K, Ohgaki H, Nakasoine Y, Fujisawa T, Shono N, Hinihara T, Hirabayashi K: Laryngeal epithelial changes on effects of smoking and drinking. Auris Nasus Larynx 1990; 17: 105-14.
21. Stanley PJ, Wilson R, Greenstone MA, Mac William L, Cole PJ: Effect of cigarette smoking on nasal mucociliary clearance and ciliary beat frequency. Thorax 1986; 41: 519-23.
22. Park SS, Kikkawa Y, Goldring IP, Daly MM, Zelefsky M, Shim C, Sprierer M, Morita T: An animal model of cigarette smoking in beagle dogs. Am Rev Respir Dis 1977; 115: 971-9.
23. Dua K, Bardan E, Ren J, Sui Z, Shaker R: Effect of chronic and acute cigarette smoking on the pharyngo-upper oesophageal sphincter contractile reflex and reflexive pharyngeal swallow. Gut 1998; 43: 537-41.
24. Piatt G, Gazzola T, Allegra L: Bacterial adherence in smokers and non-smokers. Pharmacol Res 1997; 36: 481-4.
25. Özlü T, Çay M, Akbulut A, Yekeler H, Naziroglu M and Aksakal M: The facilitating effect of cigarette smoke on the colonization of instilled bacteria into the tracheal lumen in rats and the improving influence of supplementary vitamin E on this process. Respirology 1999; 4: 245.
26. Adesina A, Vallyathan E, McQuillen S, Weaver O, Craighead JE: Bronchiolar inflammation and fibrosis associated with smoking: a morphologic cross-sectionnal population analysis. Am Rev Respir Dis 1991; 143: 144.
27. Sopori M, Goud S, Kaplan A: Effects of tabaco smoke on the immune system. Immunotoxicology and immunopharmacology 1994. Eds Raven Press, New york, 413 pages.
28. Plowman PN: The pulmonary macrophage population of human smokers. Ann Occup Hyg 1982; 25: 393.
29. Matsunaga K, Klein TW, Friedman H, Yamamoto Y: Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 2001; 167: 6518-24.
30. Ohta T, Yamashita N, Maruyama M, Sugiyama E, Okayashi IM: Cigarette smoking decreases interleukin-8 secretion by human alveolar macrophages. Respir Med 1998; 92: 922-7.
31. Soliman DM, Twigg HL: Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages. Am J Physiol 1992; 263: 471-8.
32. Zeidel A, Beilin B, Yardeni I, Mayburg E, Smirnov G, Bessler H: Immune response in asymptomatic smokers. Acta Anaesthesiol scand 2002; 46: 959-64.
33. Chen YH, Chen SH, Jong A, Zhou ZY, Li W, Suzuki K, Huang SH: Enhanced Escherichia coli invasion of human brain microvascular endothelial cells is associated with alternations in cytoskeleton induced by nicotine. Cell Microbiol 2002; 4: 503-14.
34. Robbins CS, Dawe DE, Goncharova SI, Pouladi MA, Drannik AG, Swirski FK, Cox G, Stampfli MR: Cigarette smoke decreases pulmonary dendritic cells and impacts anti-viral immune responsiveness. Am J Respir Cell Mol Biol 2004; 30: 202-11.
35. Almirall J, Gonzales CA, Balanzo X, Bolibar I: Proportion of community-acquired pneumoniae cases attribuable to tobacco smoking. Chest 1999; 116: 375-9.